Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 5 days agoWhat does donanemab do? Donanemab is the third so-called "disease-modifying treatment" for Alzheimer...
'I'm a Cleveland Clinic Neuropsychologist—These Are 3 Symptoms of Brain Disease That Can Actually...
Parade via Yahoo News· 2 days agoHowever, before hitting the panic button, Dr. Caldwell reiterates that dementia onset (and even ...
Thousands face missing out on new Alzheimer’s treatments unless testing overhauled
The Telegraph via Yahoo News· 5 days agoResearchers from University College London (UCL) said just 14 per cent of patients referred to...
New test may predict dementia up to 9 years before diagnosis with 80% accuracy
MedicalNewsToday via AOL· 6 days agoIts authors say the model is greater than 80% accurate and can predict disease up to nine years...
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
Fox News via Yahoo News· 5 days agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration...
Annovis Bio plans large study to test experimental drug in early Alzheimer's patients - Philadelphia...
The Business Journals· 4 days agoAnnovis Bio, based on analysis of the mixed results from its most recent study, plans to focus the...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 6 days agoThe trial found participants who were given donanemab declined 22% slower than those who were in the...
A new drug could slow Alzheimer's. But can patients get it?
Today's News-Herald· 5 hours agoIf given the agency’s green light later this year, it would be the second drug to target amyloid...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 6 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 5 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...